The board of XVIVO Perfusion AB (publ) has appointed Christoffer Rosenblad as CEO. Christoffer has had the role of acting CEO since September 27, 2022 and will take up his permanent role immediately. Upon completion of a clear requirement profile, the board found that Christoffer Rosenblad meets the requirements requested.

The board believes that Christoffer Rosenblad is the most suitable candidate to lead XVIVO during the next phase of the Company's development. In the last 10 years, Christoffer has held several leading positions in the company, such as acting CEO, COO, CFO and CEO for XVIVO North America. Christoffer has also been responsible for business development and successfully led acquisition processes in recent years.